Business Description
China SXT Pharmaceuticals Inc
ISIN : VGG2161P1403
Share Class Description:
SXTC: Ordinary SharesDescription
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.64 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.62 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.34 | |||||
| Beneish M-Score | -3.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -74.2 | |||||
| 3-Year EBITDA Growth Rate | 38 | |||||
| 3-Year EPS without NRI Growth Rate | 61.2 | |||||
| 3-Year Book Growth Rate | -61 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.16 | |||||
| 9-Day RSI | 33.37 | |||||
| 14-Day RSI | 34.7 | |||||
| 6-1 Month Momentum % | -26.81 | |||||
| 12-1 Month Momentum % | -64.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.47 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 1.25 | |||||
| Days Inventory | 186.45 | |||||
| Days Sales Outstanding | 427.16 | |||||
| Days Payable | 480.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -197.7 | |||||
| Shareholder Yield % | -302.15 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.7 | |||||
| Operating Margin % | -810.69 | |||||
| Net Margin % | -830.07 | |||||
| FCF Margin % | -9.57 | |||||
| ROE % | -122.36 | |||||
| ROA % | -63.94 | |||||
| ROIC % | -124.52 | |||||
| ROC (Joel Greenblatt) % | -1125.37 | |||||
| ROCE % | -117.65 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.35 | |||||
| PB Ratio | 0.15 | |||||
| Price-to-Tangible-Book | 0.15 | |||||
| EV-to-EBIT | 0.56 | |||||
| EV-to-EBITDA | 0.57 | |||||
| EV-to-Revenue | -4.53 | |||||
| EV-to-FCF | 47.29 | |||||
| Price-to-Net-Current-Asset-Value | 0.19 | |||||
| Price-to-Net-Cash | 0.38 | |||||
| Earnings Yield (Greenblatt) % | 178.57 | |||||
| FCF Yield % | -27.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SXTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China SXT Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.703 | ||
| EPS (TTM) ($) | -29.048 | ||
| Beta | 1.96 | ||
| Volatility % | 123.14 | ||
| 14-Day RSI | 34.7 | ||
| 14-Day ATR ($) | 0.255956 | ||
| 20-Day SMA ($) | 1.42 | ||
| 12-1 Month Momentum % | -64.17 | ||
| 52-Week Range ($) | 0.9401 - 9.375 | ||
| Shares Outstanding (Mil) | 0.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China SXT Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China SXT Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
China SXT Pharmaceuticals Inc Frequently Asked Questions
What is China SXT Pharmaceuticals Inc(SXTC)'s stock price today?
The current price of SXTC is $1.03. The 52 week high of SXTC is $9.38 and 52 week low is $0.94.
When is next earnings date of China SXT Pharmaceuticals Inc(SXTC)?
The next earnings date of China SXT Pharmaceuticals Inc(SXTC) is 2024-05-31 Est..
Does China SXT Pharmaceuticals Inc(SXTC) pay dividends? If so, how much?
China SXT Pharmaceuticals Inc(SXTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers